Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
---|
08/27/2013 | US8518409 System for selective cell treatment using ideotypically modulated pharmacoeffectors |
08/27/2013 | US8518374 Personal care products with visual indicator of vaginitis |
08/27/2013 | US8517938 Medical system having consumables monitoring |
08/27/2013 | US8517723 Methods for drying a viral vaccine |
08/27/2013 | CA2763047C High throughput device for screening candidate compounds for activity against target ion channels |
08/27/2013 | CA2599843C Selective glycosidase inhibitors, methods of making inhibitors, and uses thereof |
08/27/2013 | CA2568015C Influenza hemagglutinin and neuraminidase variants |
08/27/2013 | CA2531630C Glutamine:fructose-6-phosphate amidotransferase (gfat) comprising an internal purification marker and use thereof for the screening of compounds |
08/27/2013 | CA2505515C Fret probes and methods for detecting interacting molecules |
08/27/2013 | CA2461139C Method for producing a normalized gene library from nucleic acid extracts of soil samples and the use thereof |
08/27/2013 | CA2451992C Systems and methods for monitoring behavior informatics |
08/27/2013 | CA2411465C Visual-servoing optical microscopy |
08/27/2013 | CA2400441C Nucleic acid molecule encoding a mismatch endonuclease and methods of use thereof |
08/27/2013 | CA2291861C Zinc finger protein derivatives and methods therefor |
08/22/2013 | WO2013123525A1 Uses of ided nanostructures in nucleic acid technology |
08/22/2013 | WO2013123521A1 Methods, Compounds and Compositions for Treatment of Parainfluenza Virus in Immunocompromised Patients |
08/22/2013 | WO2013123501A1 Detection and quantification of analytes based on signal induced by alkaline phosphate |
08/22/2013 | WO2013123481A1 Methods and kit for characterizing the modified base status of a transcriptome |
08/22/2013 | WO2013123463A1 A system and method of genomic profiling |
08/22/2013 | WO2013123450A1 Methods for creating bilayers for use with nanopore sensors |
08/22/2013 | WO2013123440A1 Rnase h-based rna profiling |
08/22/2013 | WO2013123411A1 Methods for diagnosing and treating cancer |
08/22/2013 | WO2013123403A1 Theranostics platform and methods of use |
08/22/2013 | WO2013123330A1 Methods and compositions for identifying repeating sequences in nucleic acids |
08/22/2013 | WO2013123258A1 Polymerase enzyme substrates with protein shield |
08/22/2013 | WO2013123238A1 Methods of isothermal amplification using blocked primers |
08/22/2013 | WO2013123220A1 Method for relative quantification of nucleic acid sequence, expression, or copy changes, using combined nuclease, ligation, and polymerase reactions |
08/22/2013 | WO2013123189A1 Impedence-based bacterial detection system |
08/22/2013 | WO2013123178A1 Apparatus, methods, and applications for point of care multiplexed diagnostics |
08/22/2013 | WO2013123125A1 Assembly of nucleic acid sequences in emulsions |
08/22/2013 | WO2013123045A1 Novel screening methods |
08/22/2013 | WO2013123035A1 System and method for processing and detecting nucleic acids |
08/22/2013 | WO2013123031A2 Highly sensitive method for detecting low frequency mutations |
08/22/2013 | WO2013123030A2 Blood collection device for improved nucleic acid regulation |
08/22/2013 | WO2013122996A1 Mirna analysis methods |
08/22/2013 | WO2013122852A1 Biological sterilization indicator devices and methods of use |
08/22/2013 | WO2013122816A1 Methods for genome-wide screening and construction of genetic interaction maps |
08/22/2013 | WO2013122689A1 Devices and methods for biomolecule detection |
08/22/2013 | WO2013122611A2 New method for decontamination and processing of clinical specimens from a patient |
08/22/2013 | WO2013122609A1 Methods of using cdk8 antagonists |
08/22/2013 | WO2013122470A1 Methods of differentiating hypoactive sexual desire disorder and/or female sexual arousal disorder |
08/22/2013 | WO2013122453A1 Device and method for detection of nucleic acid(s) |
08/22/2013 | WO2013122321A1 Use of hdac6 as hepatoma diagnosis marker and therapeutic agent |
08/22/2013 | WO2013121228A1 Endonucleases |
08/22/2013 | WO2013121224A1 Analysis of measurements of a polymer |
08/22/2013 | WO2013121048A1 New method for prognosing the survival of patients suffering from chronic myelomonocytic leukaemia |
08/22/2013 | WO2013121038A1 Mammalian homologues of flower, their use in cancer diagnostics, prevention and treatment |
08/22/2013 | WO2013098562A3 Enzyme method |
08/22/2013 | WO2013097061A8 Bs and rrbs sequencing-based bioinformatics analysis method and device |
08/22/2013 | WO2013090386A3 Methods and kits for room temperature in situ detection of a target nucleic acid in a biological sample |
08/22/2013 | WO2013084075A3 Methods of detecting mutations and epigenetic changes |
08/22/2013 | WO2013062261A3 Newly identified colon cancer marker and diagnostic kit using the same |
08/22/2013 | WO2013057495A3 Method of characterizing a target polynucleotide using a pore and a hel308 helicase |
08/22/2013 | WO2013054200A3 Methods and compositions for screening and treating developmental disorders |
08/22/2013 | WO2013050881A3 Direct nucleic acid analysis |
08/22/2013 | WO2012089772A3 Complex set of mirnas as non-invasive biomarkers for prostate diseases |
08/22/2013 | US20130219555 Pathogen-inducible promoters and their use in enhancing the disease resistance of plants |
08/22/2013 | US20130219536 Lrrk2 polynucleotides and trangenic animals |
08/22/2013 | US20130219533 Pla2g16 as a target for antiviral compounds |
08/22/2013 | US20130219531 Immortalized human prostate cell lines |
08/22/2013 | US20130218034 System for quantifying blood flow in tissue and updating tissue baseline conditions |
08/22/2013 | US20130217870 Nucleic acids and methods for detecting turfgrass pathogenic fungi |
08/22/2013 | US20130217786 Porous nanostructures and methods involving the same |
08/22/2013 | US20130217721 Compositions and methods for detection and treatment of b-raf inhibitor-resistant melanomas |
08/22/2013 | US20130217713 Predictive marker for egfr inhibitor treatment |
08/22/2013 | US20130217712 Predictive marker for egfr inhibitor treatment |
08/22/2013 | US20130217656 Methods and compositions for diagnosing and treating lupus |
08/22/2013 | US20130217595 Method for the identification of catechol o-methyltransferase modulators |
08/22/2013 | US20130217594 Methods for screening compounds for capability to inhibit premalignant squamous epithelial cell progression to a malignant state |
08/22/2013 | US20130217593 Bioluminescent assays utilising secreted luciferases |
08/22/2013 | US20130217591 Marker Sequences for Inflammatory Prostate Diseases, Prostate Carconoma and Their Use |
08/22/2013 | US20130217590 Methods for determining a prognosis for survival for a patient with leukaemia |
08/22/2013 | US20130217588 Methods for Identifying Eubacteria |
08/22/2013 | US20130217587 High density sensor array without wells |
08/22/2013 | US20130217586 Method of nucleic acid amplification |
08/22/2013 | US20130217585 Quantitative Total Definition of Biologically Active Sequence Elements |
08/22/2013 | US20130217584 Microarray-based assay integrated with particles for analyzing molecular interactions |
08/22/2013 | US20130217583 Microfluidic devices and methods of use in the formation and control of nanoreactors |
08/22/2013 | US20130217115 Plasmid standard for use in quantitative assays using fluorescent quantitative pcr |
08/22/2013 | US20130217107 Biological sterilization indicator system and method |
08/22/2013 | US20130217106 Biochemical analysis apparatus and rotary valve |
08/22/2013 | US20130217063 Rapid microbial detection and antimicrobial susceptibility testing |
08/22/2013 | US20130217062 Method for evaluating the improvement of skin elasticity using a mimetic dermis |
08/22/2013 | US20130217061 Apparatus for Systematic Single Cell Tracking of Distinctive Cellular Events |
08/22/2013 | US20130217056 Quantification of non-reducing end glycan residual compounds |
08/22/2013 | US20130217055 Method for predicting tyrosine kinase inhibitor (tki) resistance in patients suffering from chronic myelogenous leukemia (cml) |
08/22/2013 | US20130217052 Luciferase-based assays |
08/22/2013 | US20130217051 Luciferase-based assays |
08/22/2013 | US20130217046 Method for determining predisposition to esophageal-related disorders |
08/22/2013 | US20130217041 Detection of biological molecules by differential partitioning of enzyme substrates and products |
08/22/2013 | US20130217033 Biomarker for monitoring development of diseases and assessing the efficacy of therapies |
08/22/2013 | US20130217029 System for airborne bacterial sample collection and analysis |
08/22/2013 | US20130217028 Peripheral blood gene markers for early diagnosis of parkinson's disease |
08/22/2013 | US20130217027 Agents providing controls and standards for immuno-precipitation assays |
08/22/2013 | US20130217026 Microfluidic cartridge |
08/22/2013 | US20130217025 Chimeric dna identifier |
08/22/2013 | US20130217024 Methods for diagnosing bacteremia and fungemi |
08/22/2013 | US20130217023 System And Method For Generation And Use Of Compact Clonally Amplified Products |
08/22/2013 | US20130217021 Method for detecting and examining traumatic brain injury in vitro |
08/22/2013 | US20130217020 Methods for improving sensitivity and specificity of screening assays of kras codons 12 and 13 mutations |